Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization

BackgroundTransarterial chemoembolization (TACE) stands for the most commonly utilized therapy for hepatocellular carcinoma (HCC) worldwide. This study was to explore the potential predictive and prognostic roles of LAG-3 and PD-L1 as serum biomarkers in HCC patients underwent TACE treatment.Methods...

Descrición completa

Detalles Bibliográficos

Principais autores:	Mengzhou Guo, Feng Qi, Qianwen Rao, Jialei Sun, Xiaojing Du, Zhuoran Qi, Biwei Yang, Jinglin Xia
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Immunology
Assuntos:	LAG-3 PD-L1 hepatocellular carcinoma transarterial chemoembolization tumor response
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.754961/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!